Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [963]

Sevabertinib shows manageable diarrhoea without impacting efficacy in HER2...

Prof Nicolas Girard - Institut Curie, Paris, France

Sevabertinib shows manageable diarrhoea without impacting efficacy in HER2-mutant lung cancer ( Prof Nicolas Girard - Institut Curie, Paris, France )

Subcutaneous amivantamab plus lazertinib shows durable responses in EGFR-mutant...

Prof Nicolas Girard - Institut Curie, Paris, France

Subcutaneous amivantamab plus lazertinib shows durable responses in EGFR-mutant advanced lung cancer ( Prof Nicolas Girard - Institut Curie, Paris, France )

Distinct lung microbiome patterns identified in Portuguese patients with lung...

Dr Telma Sequeira - CUF Tejo, Lisbon, Portugal

Distinct lung microbiome patterns identified in Portuguese patients with lung cancer ( Dr Telma Sequeira - CUF Tejo, Lisbon, Portugal )

Artificial intelligence PD-L1 scoring matches pathologists and improves...

Prof Fred Hirsch - Icahn School of Medicine at Mount Sinai, New York, USA

Artificial intelligence PD-L1 scoring matches pathologists and improves reproducibility in lung cancer testing ( Prof Fred Hirsch - Icahn School of Medicine at Mount Sinai, New York, USA )

T-cell engagers in lung cancer: Strategies to prevent and manage toxicities

Dr Myung-Ju Ahn - Sungkyunkwan University School of Medicine, Seoul, South Korea

T-cell engagers in lung cancer: Strategies to prevent and manage toxicities ( Dr Myung-Ju Ahn - Sungkyunkwan University School of Medicine, Seoul, South Korea )

Low-dose CT screening reduces lung cancer mortality and improves survival in...

Dr Caichen Li - Guangzhou Medical University, Guangzhou, China

Low-dose CT screening reduces lung cancer mortality and improves survival in broad populations ( Dr Caichen Li - Guangzhou Medical University, Guangzhou, China )

Cracking the code: Bispecific immunotherapy in small cell lung cancer

Prof Helena Linardou - Metropolitan Hospital, Athens, Greece

Cracking the code: Bispecific immunotherapy in small cell lung cancer ( Prof Helena Linardou - Metropolitan Hospital, Athens, Greece )

ATR inhibitor plus durvalumab does not improve survival over docetaxel in...

Prof Benjamin Besse - Institut Gustave Roussy, Villejuif, France

ATR inhibitor plus durvalumab does not improve survival over docetaxel in advanced NSCLC ( Prof Benjamin Besse - Institut Gustave Roussy, Villejuif, France )

Durvalumab after SBRT reduces tumour progression in early-stage NSCLC

Dr Andreas Hallqvist - Sahlgrenska University Hospital, Göteborg, Sweden

Durvalumab after SBRT reduces tumour progression in early-stage NSCLC ( Dr Andreas Hallqvist - Sahlgrenska University Hospital, Göteborg, Sweden )

Gotistobart improves survival and response over docetaxel in previously treated...

Dr Kai He - The Ohio State University Comprehensive Cancer Center, Columbus, USA

Gotistobart improves survival and response over docetaxel in previously treated squamous lung cancer ( Dr Kai He - The Ohio State University Comprehensive Cancer Center, Columbus, USA )

Reducing cancer burden through prevention

Dr Ernesto Gil Deza - Instituto Henry Moore, Buenos Aires, Argentina

Reducing cancer burden through prevention ( Dr Ernesto Gil Deza - Instituto Henry Moore, Buenos Aires, Argentina )

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD...

Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform ( Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA )

More from ecancer